Redox control of the survival of healthy and diseased cells

Antioxidants and Redox Signaling

Volumn 15, Issue 11, 2011, Pages 2867-2902

  Zhang, Yuxing ^a,b   Du, Yanzhi ^a   Le, Weidong ^a   Wang, Kankan ^a   Kieffer, Nelly ^c   Zhang, Ji ^a,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALLOPURINOL; ANTIOXIDANT; APOCYNIN; ARSENIC TRIOXIDE; ASCORBIC ACID; BETA CATENIN; BUTYLATED HYDROXYANISOLE; DIPHENYLIODONIUM SALT; FENRETINIDE; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMATINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOQUINONE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; RETINOIC ACID; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR NRF1; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; UNINDEXED DRUG; WNT PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ATHEROSCLEROSIS; AUTOPHAGY; BREAST CANCER; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC MYELOID LEUKEMIA; DEGENERATIVE DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; EPIGENETICS; GOUT; HEART MUSCLE ISCHEMIA; HOMEOSTASIS; HUMAN; HYPERTENSION; HYPOGLYCEMIA; NEOPLASM; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOGENESIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROSTATE CANCER; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; SKIN CANCER; UNSPECIFIED SIDE EFFECT;

ANIMALS; ATHEROSCLEROSIS; CELL SURVIVAL; DIABETES MELLITUS; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASMS; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 80054703165     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3685     Document Type: Review

References (427)

1. Adibhatla RM and Hatcher JF. Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 12: 125-169, 2010.
2. Adlam VJ, Harrison JC, Porteous CM, James AM, Smith RA, Murphy MP, and Sammut IA. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J 19: 1088-1095, 2005. (Pubitemid 40946434)
3. Aguirre V, Uchida T, Yenush L, Davis R, and White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275: 9047-9054, 2000. (Pubitemid 30180265)
4. Ahsan MK, Lekli I, Ray D, Yodoi J, and Das DK. Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart. Antioxid Redox Signal 11: 2741-2758, 2009.
5. Alam J, Stewart D, Touchard C, Boinapally S, Choi AM, and Cook JL. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 274: 26071-26078, 1999.
6. Alam ZI, Jenner A, Daniel SE, Lees AJ, Cairns N, Marsden CD, Jenner P, and Halliwell B. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem 69: 1196-1203, 1997. (Pubitemid 27364841)
7. Aldieri E, Riganti C, Polimeni M, Gazzano E, Lussiana C, Campia I, and Ghigo D. Classical inhibitors of NOX NAD(P)H oxidases are not specific. Curr Drug Metab 9: 686-696, 2008.
8. Alter O, Brown PO, and Botstein D. Singular value decomposition for genome-wide expression data processing and modeling. Proc Natl Acad Sci USA 97: 10101-10106, 2000.
9. Amaya Y, Yamazaki K, Sato M, Noda K, and Nishino T. Proteolytic conversion of xanthine dehydrogenase from the NAD-dependent type to the O2-dependent type. Amino acid sequence of rat liver xanthine dehydrogenase and identification of the cleavage sites of the enzyme protein during irreversible conversion by trypsin. J Biol Chem 265: 14170-14175, 1990.
10. Anandatheerthavarada HK, Biswas G, Robin MA, and Avadhani NG. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 161: 41-54, 2003. (Pubitemid 36459078)
11. Anderson CP, Tsai J, Chan W, Park CK, Tian L, Lui RM, Forman HJ, and Reynolds CP. Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines. Eur J Cancer 33: 2016-2019, 1997. (Pubitemid 28123446)
12. Andreyev AY, Kushnareva YE, and Starkov AA. Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc) 70: 200-214, 2005. (Pubitemid 40512329)
13. Appierto V, Tiberio P, Villani MG, Cavadini E, and Formelli F. PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation. Carcinogenesis 30: 824-831, 2009.
14. Ardies CM. Inflammation as cause for scar cancers of the lung. Integr Cancer Ther 2: 238-246, 2003. (Pubitemid 37127930)
15. Armstrong JS. Mitochondrial medicine: pharmacological targeting of mitochondria in disease. Br J Pharmacol 151: 1154-1165, 2007. (Pubitemid 47255892)
16. Armstrong JS and Jones DP. Glutathione depletion enforces the mitochondrial permeability transition and causes cell death in Bcl-2 overexpressing HL60 cells. FASEB J 16: 1263-1265, 2002.
17. Azad MB, Chen Y, and Gibson SB. Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment. Antioxid Redox Signal 11: 777-790, 2009.
18. Bamberger ME and Landreth GE. Inflammation, apoptosis, and Alzheimer's disease. Neuroscientist 8: 276-283, 2002. (Pubitemid 34538795)
19. Barrientos A, Casademont J, Cardellach F, Estivill X, Urbano-Marquez A, and Nunes V. Reduced steady-state levels of mitochondrial RNA and increased mitochondrial DNA amount in human brain with aging. Brain Res Mol Brain Res 52: 284-289, 1997. (Pubitemid 28043472)
20. Bashan N, Kovsan J, Kachko I, Ovadia H, and Rudich A. Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiol Rev 89: 27-71, 2009.
21. Basuroy S, Tcheranova D, Bhattacharya S, Leffler CW, and Parfenova H. Nox4 NADPH oxidase-derived reactive oxygen species, via endogenous carbon monoxide, promote survival of brain endothelial cells during TNF-{alpha}-induced apoptosis. Am J Physiol Cell Physiol, 300: C256-C265, 2011.
22. Baudry N, Laemmel E, and Vicaut E. In vivo reactive oxygen species production induced by ischemia in muscle arterioles of mice: involvement of xanthine oxidase and mitochondria. Am J Physiol Heart Circ Physiol 294: H821-H828, 2008. (Pubitemid 351253293)
23. Bedard K and Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313, 2007. (Pubitemid 46209993)
24. Bell EL, Klimova T, and Chandel NS. Targeting the mitochondria for cancer therapy: regulation of hypoxiainducible factor by mitochondria. Antioxid Redox Signal 10: 635-640, 2008.
25. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, and Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3: 1301-1306, 2000.
26. Bienert GP, Schjoerring JK, and Jahn TP. Membrane transport of hydrogen peroxide. Biochim Biophys Acta 1758: 994-1003, 2006. (Pubitemid 44373854)
27. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, and Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297: 842-857, 2007. (Pubitemid 46333949)
28. Block K, Ricono JM, Lee DY, Bhandari B, Choudhury GG, Abboud HE, and Gorin Y. Arachidonic acid-dependent activation of a p22(phox)-based NAD(P)H oxidase mediates angiotensin II-induced mesangial cell protein synthesis and fibronectin expression via Akt/PKB. Antioxid Redox Signal 8: 1497-1508, 2006. (Pubitemid 44726326)
29. Block ML. NADPH oxidase as a therapeutic target in Alzheimer's disease. BMC Neurosci 9 Suppl 2: S8, 2008.
30. Bloom DA and Jaiswal AK. Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response elementmediated NAD(P)H:quinone oxidoreductase-1 gene expression. J Biol Chem 278: 44675-44682, 2003. (Pubitemid 37377224)
31. Boden G. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Curr Diab Rep 6: 177-181, 2006.
32. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, and Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: 256-259, 2003. (Pubitemid 36131051)
33. Bonny C, Oberson A, Negri S, Sauser C, and Schorderet DF. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 50: 77-82, 2001. (Pubitemid 32047984)
34. Borges F, Fernandes E, and Roleira F. Progress towards the discovery of xanthine oxidase inhibitors. Curr Med Chem 9: 195-217, 2002. (Pubitemid 34436441)
35. Boveris A, Oshino N, and Chance B. The cellular production of hydrogen peroxide. Biochem J 128: 617-630, 1972.
36. Brahimi-Horn MC, Chiche J, and Pouyssegur J. Hypoxia and cancer. J Mol Med 85: 1301-1307, 2007. (Pubitemid 50004093)
37. Brandes RP and Schroder K. Differential vascular functions of Nox family NADPH oxidases. Curr Opin Lipidol 19: 513-518, 2008.
38. Brown DI and Griendling KK. Nox proteins in signal transduction. Free Radic Biol Med 47: 1239-1253, 2009.
39. Bui T and Thompson CB. Cancer's sweet tooth. Cancer Cell 9: 419-420, 2006. (Pubitemid 43832194)
40. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 18: 775-794, 1995.
41. Cadenas E, Boveris A, Ragan CI, and Stoppani AO. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch Biochem Biophys 180: 248-257, 1977. (Pubitemid 8115490)
42. Cadenas E and Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29: 222-230, 2000.
43. Cai X, Shen YL, Zhu Q, Jia PM, Yu Y, Zhou L, Huang Y, Zhang JW, Xiong SM, Chen SJ, Wang ZY, Chen Z, and Chen GQ. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia 14: 262-270, 2000. (Pubitemid 30095381)
44. Calnan DR and Brunet A. The FoxO code. Oncogene 27: 2276-2288, 2008. (Pubitemid 351501779)
45. Cannito S, Novo E, Compagnone A, Valfre di Bonzo L, Busletta C, Zamara E, Paternostro C, Povero D, Bandino A, Bozzo F, Cravanzola C, Bravoco V, Colombatto S, and Parola M. Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis 29: 2267-2278, 2008.
46. Carlsson C, Borg LA, and Welsh N. Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro. Endocrinology 140: 3422-3428, 1999. (Pubitemid 30645397)
47. Castellani ML, Shaik YB, Shanmugham LN, Frydas S, Madhappan B, Salini V, Vecchiet J, Mastrangelo F, Riccioni G, Conti F, Perrella A, Conti P, and Tete S. Role of flavonoids and vitamins in cancer. Riv Biol 100: 39-54, 2007. (Pubitemid 46982516)
48. Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, and Shah AM. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 8: 691-728, 2006. (Pubitemid 44043102)
49. Cerutti PA. Prooxidant states and tumor promotion. Science 227: 375-381, 1985. (Pubitemid 15153495)
50. Chacko B, Reily C, Srivastava A, Johnson MS, Ulasova E, Agarwal A, Zinn K, Murphy MP, Kalyanaraman B, and Darley-Usmar V. Prevention of diabetic nephropathy in Ins2 +/-AkitaJ mice by the mitochondria-targeted therapy Mito Q. Biochem J 432: 9-19, 2010.
51. Chambers DE, Parks DA, Patterson G, Roy R, McCord JM, Yoshida S, Parmley LF, and Downey JM. Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol 17: 145-152, 1985. (Pubitemid 16241099)
52. Chan DW, Liu VW, Tsao GS, Yao KM, Furukawa T, Chan KK, and Ngan HY. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells. Carcinogenesis 29: 1742-1750, 2008.
53. Chen GQ, Shi XG, Tang W, Xiong SM, Zhu J, Cai X, Han ZG, Ni JH, Shi GY, Jia PM, Liu MM, He KL, Niu C, Ma J, Zhang P, Zhang TD, Paul P, Naoe T, Kitamura K, Miller W, Waxman S, Wang ZY, de The H, Chen SJ, and Chen Z. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood 89: 3345-3353, 1997.
54. Chen KC, Zhou Y, Zhang W, and Lou MF. Control of PDGF-induced reactive oxygen species (ROS) generation and signal transduction in human lens epithelial cells. Mol Vis 13: 374-387, 2007. (Pubitemid 46421651)
55. Chen W, Gabel S, Steenbergen C, and Murphy E. A redoxbased mechanism for cardioprotection induced by ischemic preconditioning in perfused rat heart. Circ Res 77: 424-429, 1995.
56. Chiesa F, Tradati N, Grigolato R, Boracchi P, Biganzoli E, Crose N, Cavadini E, Formelli F, Costa L, Giardini R, Zurrida S, Costa A, De Palo G, and Veronesi U. Randomized trial of fenretinide (4-HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: long-term results. Int J Cancer 115: 625-629, 2005. (Pubitemid 40656722)
57. Chinta SJ and Andersen JK. Redox imbalance in Parkinson's disease. Biochim Biophys Acta 1780: 1362-1367, 2008.
58. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, and Green DR. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303: 1010-1014, 2004. (Pubitemid 38209704)
59. Cho S, Szeto HH, Kim E, Kim H, Tolhurst AT, and Pinto JT. A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36. J Biol Chem 282: 4634-4642, 2007. (Pubitemid 47100960)
60. Chung FL, Pan J, Choudhury S, Roy R, Hu W, and Tang MS. Formation of trans-4-hydroxy-2-nonenal-and other enal-derived cyclic DNA adducts from omega-3 and omega-6 polyunsaturated fatty acids and their roles in DNA repair and human p53 gene mutation. Mutat Res 531: 25-36, 2003. (Pubitemid 37456722)
61. Circu ML and Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48: 749-762, 2010.
62. Coussens LM and Werb Z. Inflammation and cancer. Nature 420: 860-867, 2002. (Pubitemid 36019639)
63. Crouch PJ, Blake R, Duce JA, Ciccotosto GD, Li QX, Barnham KJ, Curtain CC, Cherny RA, Cappai R, Dyrks T, Masters CL, and Trounce IA. Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42. J Neurosci 25: 672-679, 2005.
64. Csordas G and Hajnoczky G. SR/ER-mitochondrial local communication: calcium and ROS. Biochim Biophys Acta 1787: 1352-1362, 2009.
65. Cuervo AM. Autophagy: many paths to the same end. Mol Cell Biochem 263: 55-72, 2004. (Pubitemid 39256145)
66. Dai J, Weinberg RS, Waxman S, and Jing Y. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93: 268-277, 1999. (Pubitemid 29019412)
67. Dalle-Donne I, Giustarini D, Rossi R, Colombo R, and Milzani A. Reversible S-glutathionylation of Cys 374 regulates actin filament formation by inducing structural changes in the actin molecule. Free Radic Biol Med 34: 23-32, 2003. (Pubitemid 36043883)
68. Dalle-Donne I, Milzani A, Gagliano N, Colombo R, Giustarini D, and Rossi R. Molecular mechanisms and potential clinical significance of S-glutathionylation. Antioxid Redox Signal 10: 445-473, 2008.
69. Darios F, Corti O, Lucking CB, Hampe C, Muriel MP, Abbas N, Gu WJ, Hirsch EC, Rooney T, Ruberg M, and Brice A. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet 12: 517-526, 2003. (Pubitemid 36305590)
70. Davi G, Chiarelli F, Santilli F, Pomilio M, Vigneri S, Falco A, Basili S, Ciabattoni G, and Patrono C. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. Circulation 107: 3199-3203, 2003. (Pubitemid 36793091)
71. De Cristofaro R, Rocca B, Vitacolonna E, Falco A, Marchesani P, Ciabattoni G, Landolfi R, Patrono C, and Davi G. Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus. J Thromb Haemost 1: 250-256, 2003.
72. de la Asuncion JG, Millan A, Pla R, Bruseghini L, Esteras A, Pallardo FV, Sastre J, and Vina J. Mitochondrial glutathione oxidation correlates with age-associated oxidative damage to mitochondrial DNA. FASEB J 10: 333-338, 1996. (Pubitemid 26079953)
73. de la Torre JC. Is Alzheimer's disease preceded by neurodegeneration or cerebral hypoperfusion? Ann Neurol 57: 783-784, 2005. (Pubitemid 40798614)
74. Dechakhamphu S, Pinlaor S, Sitthithaworn P, Nair J, Bartsch H, and Yongvanit P. Lipid peroxidation and etheno DNA adducts in white blood cells of liver fluke-infected patients: protection by plasma alpha-tocopherol and praziquantel. Cancer Epidemiol Biomarkers Prev 19: 310-318, 2010.
75. Delhalle S, Deregowski V, Benoit V, Merville MP, and Bours V. NF-kappaB-dependent MnSOD expression protects adenocarcinoma cells from TNF-alpha-induced apoptosis. Oncogene 21: 3917-3924, 2002. (Pubitemid 34620860)
76. Devi L, Prabhu BM, Galati DF, Avadhani NG, and Anandatheerthavarada HK. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci 26: 9057-9068, 2006. (Pubitemid 44319397)
77. Dhakshinamoorthy S, Long DJ, 2nd, and Jaiswal AK. Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens. Curr Top Cell Regul 36: 201-216, 2000.
78. Di Filippo C, Cuzzocrea S, Rossi F, Marfella R, and D'Amico M. Oxidative stress as the leading cause of acute myocardial infarction in diabetics. Cardiovasc Drug Rev 24: 77-87, 2006. (Pubitemid 46696918)
79. Diaz B, Shani G, Pass I, Anderson D, Quintavalle M, and Courtneidge SA. Tks5-dependent, nox-mediated generation of reactive oxygen species is necessary for invadopodia formation. Sci Signal 2: ra53, 2009.
80. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman IL, and Clarke MF. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458: 780-783, 2009.
81. Ding M, Kwok LY, Schluter D, Clayton C, and Soldati D. The antioxidant systems in Toxoplasma gondii and the role of cytosolic catalase in defence against oxidative injury. Mol Microbiol 51: 47-61, 2004. (Pubitemid 38031070)
82. Dragicevic N, Mamcarz M, Zhu Y, Buzzeo R, Tan J, Arendash GW, and Bradshaw PC. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. J Alzheimers Dis 20 Suppl 2: S535-S550, 2010.
83. Drose S and Brandt U. The mechanism of mitochondrial superoxide production by the cytochrome bc1 complex. J Biol Chem 283: 21649-21654, 2008.
84. Du H, Guo L, Yan S, Sosunov AA, McKhann GM, and Yan SS. Early deficits in synaptic mitochondria in an Alzhei-mer's disease mouse model. Proc Natl Acad Sci USA 107: 18670-18675, 2010.
85. Du Y, Wang K, Fang H, Li J, Xiao D, Zheng P, Chen Y, Fan H, Pan X, Zhao C, Zhang Q, Imbeaud S, Graudens E, Eveno E, Auffray C, Chen S, Chen Z, and Zhang J. Coordination of intrinsic, extrinsic, and endoplasmic reticulum-mediated apoptosis by imatinib mesylate combined with arsenic trioxide in chronic myeloid leukemia. Blood 107: 1582-1590, 2006. (Pubitemid 43242397)
86. Dyck JA, Maul GG, Miller WH, Jr., Chen JD, Kakizuka A, and Evans RM. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76: 333-343, 1994. (Pubitemid 24046695)
87. Ebert BL and Bunn HF. Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein. Mol Cell Biol 18: 4089-4096, 1998. (Pubitemid 28287932)
88. Essers MA, de Vries-Smits LM, Barker N, Polderman PE, Burgering BM, and Korswagen HC. Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science 308: 1181-1184, 2005. (Pubitemid 40696437)
89. Esteves AR, Arduino DM, Swerdlow RH, Oliveira CR, and Cardoso SM. Oxidative stress involvement in alphasynuclein oligomerization in Parkinson's disease cybrids. Antioxid Redox Signal 11: 439-448, 2009.
90. Estrela JM, Ortega A, and Obrador E. Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 43: 143-181, 2006. (Pubitemid 43860449)
91. Etienne-Manneville S and Hall A. Rho GTPases in cell biology. Nature 420: 629-635, 2002. (Pubitemid 36764489)
92. Evans GA. Designer science and the "omic" revolution. Nat Biotechnol 18: 127, 2000.
93. Evans JL, Goldfine ID, Maddux BA, and Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52: 1-8, 2003. (Pubitemid 36042100)
94. Fang H, Wang K, and Zhang J. Transcriptome and proteome analyses of drug interactions with natural products. Curr Drug Metab 9: 1038-1048, 2008.
95. Fantin VR, St-Pierre J, and Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9: 425-434, 2006. (Pubitemid 43832190)
96. Farmer DG and Kennedy S. RAGE, vascular tone and vascular disease. Pharmacol Ther 124: 185-194, 2009.
97. Fatehi-Hassanabad Z, Chan CB, and Furman BL. Reactive oxygen species and endothelial function in diabetes. Eur J Pharmacol 636: 8-17, 2010.
98. Ferraro D, Corso S, Fasano E, Panieri E, Santangelo R, Borrello S, Giordano S, Pani G, and Galeotti T. Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS). Oncogene 25: 3689-3698, 2006. (Pubitemid 43980490)
99. Fisher CJ and Goswami PC. Mitochondria-targeted antioxidant enzyme activity regulates radioresistance in human pancreatic cancer cells. Cancer Biol Ther 7: 1271-1279, 2008.
100. Fornai F, Schluter OM, Lenzi P, Gesi M, Ruffoli R, Ferrucci M, Lazzeri G, Busceti CL, Pontarelli F, Battaglia G, Pellegrini A, Nicoletti F, Ruggieri S, Paparelli A, and Sudhof TC. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc Natl Acad Sci USA 102: 3413-3418, 2005. (Pubitemid 40328059)
101. Funato Y, Michiue T, Asashima M, and Miki H. The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled. Nat Cell Biol 8: 501-508, 2006.
102. Gallogly MM and Mieyal JJ. Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr Opin Pharmacol 7: 381-391, 2007. (Pubitemid 47304000)
103. Gerschman R, Gilbert DL, Nye SW, Dwyer P, and Fenn WO. Oxygen poisoning and x-irradiation: a mechanism in common. Science 119: 623-626, 1954.
104. Giannoni E, Buricchi F, Grimaldi G, Parri M, Cialdai F, Taddei ML, Raugei G, Ramponi G, and Chiarugi P. Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival. Cell Death Differ 15: 867-878, 2008. (Pubitemid 351524429)
105. Giannoni E, Fiaschi T, Ramponi G, and Chiarugi P. Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals. Oncogene 28: 2074-2086, 2009.
106. Giles NM, Gutowski NJ, Giles GI, and Jacob C. Redox catalysts as sensitisers towards oxidative stress. FEBS Lett 535: 179-182, 2003. (Pubitemid 36126377)
107. Gius D and Spitz DR. Redox signaling in cancer biology. Antioxid Redox Signal 8: 1249-1252, 2006. (Pubitemid 44182423)
108. Golikov AP, Polumiskov V, Davydov BV, Karev VA, Bashkatova VG, Belozerov GE, Golikov PP, and Berestov AA. [Lipid peroxidation and the major factors of its activation in patients with myocardial infarction]. Kardiologiia 29: 53-59, 1989.
109. Gorogawa S, Kajimoto Y, Umayahara Y, Kaneto H, Watada H, Kuroda A, Kawamori D, Yasuda T, Matsuhisa M, Yamasaki Y, and Hori M. Probucol preserves pancreatic betacell function through reduction of oxidative stress in type 2 diabetes. Diabetes Res Clin Pract 57: 1-10, 2002. (Pubitemid 34463014)
110. Goto H, Takahashi H, Fujii H, Ikuta K, and Yokota S. N-(4-Hydroxyphenyl) retinamide (4-HPR) induces leukemia cell death via generation of reactive oxygen species. Int J Hematol 78: 219-225, 2003. (Pubitemid 37288508)
111. Granville DJ, Tashakkor B, Takeuchi C, Gustafsson AB, Huang C, Sayen MR, Wentworth P, Jr., Yeager M, and Gottlieb RA. Reduction of ischemia and reperfusioninduced myocardial damage by cytochrome P450 inhibitors. Proc Natl Acad Sci USA 101: 1321-1326, 2004. (Pubitemid 38182687)
112. Green DR and Evan GI. A matter of life and death. Cancer Cell 1: 19-30, 2002. (Pubitemid 41039172)
113. Greer EL and Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24: 7410-7425, 2005. (Pubitemid 41637981)
114. Guo W and Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5: 816-826, 2004. (Pubitemid 39336275)
115. Guo Y, Einhorn L, Kelley M, Hirota K, Yodoi J, Reinbold R, Scholer H, Ramsey H, and Hromas R. Redox regulation of the embryonic stem cell transcription factor oct-4 by thioredoxin. Stem Cells 22: 259-264, 2004. (Pubitemid 38736610)
116. Gurusamy N and Das DK. Autophagy, redox signaling, and ventricular remodeling. Antioxid Redox Signal 11: 1975-1988, 2009.
117. Hagg M and Wennstrom S. Activation of hypoxia-induced transcription in normoxia. Exp Cell Res 306: 180-191, 2005. (Pubitemid 40692782)
118. Hail N, Jr., Kim HJ, and Lotan R. Mechanisms of fenretinide-induced apoptosis. Apoptosis 11: 1677-1694, 2006. (Pubitemid 44376243)
119. Hainaut P and Milner J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res 53: 4469-4473, 1993. (Pubitemid 23304364)
120. Halestrap AP, Kerr PM, Javadov S, and Woodfield KY. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta 1366: 79-94, 1998. (Pubitemid 28467024)
121. Halliwell B and Aruoma OI. DNA damage by oxygenderived species. Its mechanism and measurement in mammalian systems. FEBS Lett 281: 9-19, 1991.
122. Hamel E, Nicolakakis N, Aboulkassim T, Ongali B, and Tong XK. Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease. Exp Physiol 93: 116-120, 2008. (Pubitemid 350293970)
123. Han YH, Kim SZ, Kim SH, and Park WH. Intracellular GSH level is a factor in As4.1 juxtaglomerular cell death by arsenic trioxide. J Cell Biochem 104: 995-1009, 2008.
124. Han YH, Kim SZ, Kim SH, and Park WH. Suppression of arsenic trioxide-induced apoptosis in HeLa cells by Nacetylcysteine. Mol Cells 26: 18-25, 2008.
125. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 11: 298-300, 1956.
126. Harmon JS, Stein R, and Robertson RP. Oxidative stressmediated, post-translational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells. J Biol Chem 280: 11107-11113, 2005. (Pubitemid 40418415)
127. Harrison D, Griendling KK, Landmesser U, Hornig B, and Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 91: 7A-11A, 2003. (Pubitemid 36351457)
128. Harrison R. Physiological roles of xanthine oxidoreductase. Drug Metab Rev 36: 363-375, 2004. (Pubitemid 38802492)
129. Hayes GR and Lockwood DH. Role of insulin receptor phosphorylation in the insulinomimetic effects of hydrogen peroxide. Proc Natl Acad Sci USA 84: 8115-8119, 1987.
130. He C and Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43: 67-93, 2009.
131. Heddleston JM, Li Z, Lathia JD, Bao S, Hjelmeland AB, and Rich JN. Hypoxia inducible factors in cancer stem cells. Br J Cancer 102: 789-795, 2010.
132. Heller FR, Descamps O, and Hondekijn JC. LDL oxidation: therapeutic perspectives. Atherosclerosis 137 Suppl: S25-S31, 1998. (Pubitemid 28294204)
133. Heumuller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schroder K, and Brandes RP. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51: 211-217, 2008. (Pubitemid 351159930)
134. Hille R and Nishino T. Flavoprotein structure and mechanism. Xanthine oxidase and xanthine dehydrogenase. FASEB J 9: 995-1003, 1995.
135. Hochhaus A, Kreil S, Corbin A, La Rosee P, Lahaye T, Berger U, Cross NC, Linkesch W, Druker BJ, Hehlmann R, Gambacorti-Passerini C, Corneo G, and D'Incalci M. Roots of clinical resistance to STI-571 cancer therapy. Science 293: 2163, 2001.
136. Hole PS, Pearn L, Tonks AJ, James PE, Burnett AK, Darley RL, and Tonks A. Ras-induced reactive oxygen species promote growth factor-independent proliferation in human CD34 + hematopoietic progenitor cells. Blood 115: 1238-1246, 2010.
137. Holland WL, Knotts TA, Chavez JA, Wang LP, Hoehn KL, and Summers SA. Lipid mediators of insulin resistance. Nutr Rev 65: S39-S46, 2007.
138. Hood L, Heath JR, Phelps ME, and Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 306: 640-643, 2004. (Pubitemid 39440903)
139. Hoogeboom D and Burgering BM. Should I stay or should I go: beta-catenin decides under stress. Biochim Biophys Acta 1796: 63-74, 2009.
140. Hoogeboom D, Essers MA, Polderman PE, Voets E, Smits LM, and Burgering BM. Interaction of FOXO with betacatenin inhibits beta-catenin/T cell factor activity. J Biol Chem 283: 9224-9230, 2008.
141. Hsieh CC, Kuro-o M, Rosenblatt KP, Brobey R, and Papaconstantinou J. The ASK1-Signalosome regulates p38 MAPK activity in response to levels of endogenous oxidative stress in the Klotho mouse models of aging. Aging (Albany NY) 2: 597-611, 2010.
142. Hsieh CC and Papaconstantinou J. Thioredoxin-ASK1 complex levels regulate ROS-mediated p38 MAPK pathway activity in livers of aged and long-lived Snell dwarf mice. FASEB J 20: 259-268, 2006. (Pubitemid 44933173)
143. Hsieh CC and Papaconstantinou J. Dermal fibroblasts from long-lived Ames dwarf mice maintain their in vivo resistance to mitochondrial generated reactive oxygen species (ROS). Aging (Albany NY) 1: 784-802, 2009.
144. Hsieh HL, Wang HH, Wu WB, Chu PJ, and Yang CM. Transforming growth factor-beta1 induces matrix metalloproteinase-9 and cell migration in astrocytes: roles of ROSdependent ERK-and JNK-NF-kappaB pathways. J Neuroinflammation 7: 88, 2010.
145. Huang HC, Nguyen T, and Pickett CB. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem 277: 42769-42774, 2002. (Pubitemid 35285650)
146. Huang Q, Wu YT, Tan HL, Ong CN, and Shen HM. A novel function of poly(ADP-ribose) polymerase-1 in modulation of autophagy and necrosis under oxidative stress. Cell Death Differ 16: 264-277, 2009.
147. Huang Z, Pinto JT, Deng H, and Richie JP, Jr. Inhibition of caspase-3 activity and activation by protein glutathionylation. Biochem Pharmacol 75: 2234-2244, 2008.
148. Huo YY, Li G, Duan RF, Gou Q, Fu CL, Hu YC, Song BQ, Yang ZH, Wu DC, and Zhou PK. PTEN deletion leads to deregulation of antioxidants and increased oxidative damage in mouse embryonic fibroblasts. Free Radic Biol Med 44: 1578-1591, 2008.
149. Hyoudou K, Nishikawa M, Kobayashi Y, Ikemura M, Yamashita F, and Hashida M. SOD derivatives prevent metastatic tumor growth aggravated by tumor removal. Clin Exp Metastasis 25: 531-536, 2008.
150. Hyoudou K, Nishikawa M, Kobayashi Y, Umeyama Y, Yamashita F, and Hashida M. PEGylated catalase prevents metastatic tumor growth aggravated by tumor removal. Free Radic Biol Med 41: 1449-1458, 2006. (Pubitemid 44466729)
151. Ihara Y, Toyokuni S, Uchida K, Odaka H, Tanaka T, Ikeda H, Hiai H, Seino Y, and Yamada Y. Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes 48: 927-932, 1999. (Pubitemid 29153099)
152. Ikeda H, Nishi S, and Sakai M. Transcription factor Nrf2/MafK regulates rat placental glutathione S-transferase gene during hepatocarcinogenesis. Biochem J 380: 515-521, 2004. (Pubitemid 38788124)
153. Ishikawa K and Hayashi J. [Mitochondria theory of tumor metastasis: ROS-generating mtDNA mutations reversibly regulate tumor cell metastasis].
154. Ishikawa K, Koshikawa N, Takenaga K, Nakada K, and Hayashi J. Reversible regulation of metastasis by ROSgenerating mtDNA mutations. Mitochondrion 8: 339-344, 2008.
155. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, and Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through bind-ing to the amino-terminal Neh2 domain. Genes Dev 13: 76-86, 1999. (Pubitemid 29045117)
156. Jacobson GM, Dourron HM, Liu J, Carretero OA, Reddy DJ, Andrzejewski T, and Pagano PJ. Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery. Circ Res 92: 637-643, 2003. (Pubitemid 36417698)
157. Jain AK, Mahajan S, and Jaiswal AK. Phosphorylation and dephosphorylation of tyrosine 141 regulate stability and degradation of INrf2: a novel mechanism in Nrf2 activation. J Biol Chem 283: 17712-17720, 2008.
158. Jaiswal AK. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med 36: 1199-1207, 2004. (Pubitemid 38526313)
159. James AM, Sharpley MS, Manas AR, Frerman FE, Hirst J, Smith RA, and Murphy MP. Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases. J Biol Chem 282: 14708-14718, 2007. (Pubitemid 47093346)
160. Jang YY and Sharkis SJ. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 110: 3056-3063, 2007. (Pubitemid 350006961)
161. Jaquet V, Scapozza L, Clark RA, Krause KH, and Lambeth JD. Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets. Antioxid Redox Signal 11: 2535-2552, 2009.
162. Jeong SY and Seol DW. The role of mitochondria in apoptosis. BMB Rep 41: 11-22, 2008.
163. Jialal I and Fuller CJ. Effect of vitamin E, vitamin C and beta-carotene on LDL oxidation and atherosclerosis. Can J Cardiol 11 Suppl G: 97G-103G, 1995.
164. Jiang F, Drummond GR, and Dusting GJ. Suppression of oxidative stress in the endothelium and vascular wall. Endothelium 11: 79-88, 2004. (Pubitemid 39207181)
165. Jin ZG, Melaragno MG, Liao DF, Yan C, Haendeler J, Suh YA, Lambeth JD, and Berk BC. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res 87: 789-796, 2000.
166. Jing Y, Dai J, Chalmers-Redman RM, Tatton WG, and Waxman S. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 94: 2102-2111, 1999. (Pubitemid 29430427)
167. Jing Y, Wang L, Xia L, Chen GQ, Chen Z, Miller WH, and Waxman S. Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo. Blood 97: 264-269, 2001. (Pubitemid 32061269)
168. Johnson F and Giulivi C. Superoxide dismutases and their impact upon human health. Mol Aspects Med 26: 340-352, 2005. (Pubitemid 41225357)
169. Kabe Y, Ando K, Hirao S, Yoshida M, and Handa H. Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 7: 395-403, 2005. (Pubitemid 40279807)
170. Kadara H, Lacroix L, Lotan D, and Lotan R. Induction of endoplasmic reticulum stress by the pro-apoptotic retinoid N-(4-hydroxyphenyl)retinamide via a reactive oxygen species-dependent mechanism in human head and neck cancer cells. Cancer Biol Ther 6: 705-711, 2007. (Pubitemid 47328351)
171. Kamata H, Honda S, Maeda S, Chang L, Hirata H, and Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120: 649-661, 2005. (Pubitemid 40343077)
172. Kaneto H, Kajimoto Y, Miyagawa J, Matsuoka T, Fujitani Y, Umayahara Y, Hanafusa T, Matsuzawa Y, Yamasaki Y, and Hori M. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 48: 2398-2406, 1999. (Pubitemid 30395432)
173. Kaneto H, Katakami N, Matsuhisa M, and Matsuoka TA. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediators Inflamm 2010: 453892, 2010.
174. Karawajew L, Rhein P, Czerwony G, and Ludwig WD. Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species. Blood 105: 4767-4775, 2005. (Pubitemid 40807302)
175. Kaspar JW, Niture SK, and Jaiswal AK. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 47: 1304-1309, 2009.
176. Katsuda S, Kaji T. Atherosclerosis and extracellular matrix. J Atheroscler Thromb 10: 267-274, 2003.
177. Kaur D and Andersen J. Does cellular iron dysregulation play a causative role in Parkinson's disease? Ageing Res Rev 3: 327-343, 2004. (Pubitemid 38844698)
178. Kawamori D, Kajimoto Y, Kaneto H, Umayahara Y, Fujitani Y, Miyatsuka T, Watada H, Leibiger IB, Yamasaki Y, and Hori M. Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH(2)-terminal kinase. Diabetes 52: 2896-2904, 2003. (Pubitemid 37466858)
179. Kawamori D, Kaneto H, Nakatani Y, Matsuoka TA, Matsuhisa M, Hori M, and Yamasaki Y. The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation. J Biol Chem 281: 1091-1098, 2006.
180. Kefaloyianni E, Gaitanaki C, and Beis I. ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts. Cell Signal 18: 2238-2251, 2006. (Pubitemid 44740489)
181. Kim WH, Goo SY, Shin MH, Chun SJ, Lee H, Lee KH, and Park SJ. Vibrio vulnificus-induced death of Jurkat T-cells requires activation of p38 mitogen-activated protein kinase by NADPH oxidase-derived reactive oxygen species. Cell Immunol 253: 81-91, 2008.
182. Kogawa K, Muramatsu H, Tanaka M, Nishihori Y, Hagiwara S, Kuribayashi K, Nakamura K, Koike K, Sakamaki S, and Niitsu Y. Enhanced inhibition of experimental metastasis by the combination chemotherapy of Cu-Zn SOD and adriamycin. Clin Exp Metastasis 17: 239-244, 1999. (Pubitemid 29360902)
183. Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, and Vercesi AE. Mitochondria and reactive oxygen species. Free Radic Biol Med 47: 333-343, 2009.
184. Kreuzer J, Viedt C, Brandes RP, Seeger F, Rosenkranz AS, Sauer H, Babich A, Nurnberg B, Kather H, and Krieger-Brauer HI. Platelet-derived growth factor activates production of reactive oxygen species by NAD(P)H oxidase in smooth muscle cells through Gi1,2. FASEB J 17: 38-40, 2003.
185. Kulawiec M, Owens KM, and Singh KK. Cancer cell mitochondria confer apoptosis resistance and promote metastasis. Cancer Biol Ther 8: 1378-1385, 2009.
186. Kunsch C and Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85: 753-766, 1999. (Pubitemid 29480816)
187. Kuphal S, Winklmeier A, and Warnecke C, Bosserhoff AK. Constitutive HIF-1 activity in malignant melanoma. Eur J Cancer 46: 1159-1169, 2010.
188. Kushnareva Y, Murphy AN, and Andreyev A. Complex Imediated reactive oxygen species generation: modulation by cytochrome c and NAD(P) + oxidation-reduction state. Biochem J 368: 545-553, 2002. (Pubitemid 35454532)
189. Kwon J, Lee SR, Yang KS, Ahn Y, Kim YJ, Stadtman ER, and Rhee SG. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc Natl Acad Sci USA 101: 16419-16424, 2004. (Pubitemid 39557728)
190. Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honore N, Doubeikovsky A, Duprez E, Pandolfi PP, Puvion E, Freemont P, and de The H. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J Exp Med 193: 1361-1371, 2001. (Pubitemid 32565965)
191. Lambert AJ and Brand MD. Inhibitors of the quinonebinding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I). J Biol Chem 279: 39414-39420, 2004. (Pubitemid 39258206)
192. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189, 2004. (Pubitemid 38339084)
193. Lambeth JD, Krause KH, and Clark RA. NOX enzymes as novel targets for drug development. Semin Immunopathol 30: 339-363, 2008.
194. Landmesser U, Spiekermann S, Preuss C, Sorrentino S, Fischer D, Manes C, Mueller M, and Drexler H. Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease. Arterioscler Thromb Vasc Biol 27: 943-948, 2007. (Pubitemid 46606729)
195. Lando D, Gorman JJ, Whitelaw ML, and Peet DJ. Oxygendependent regulation of hypoxia-inducible factors by prolyl and asparaginyl hydroxylation. Eur J Biochem 270: 781-790, 2003. (Pubitemid 36315321)
196. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, and Bruick RK. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxiainducible factor. Genes Dev 16: 1466-1471, 2002. (Pubitemid 34686328)
197. Landriscina M, Maddalena F, Laudiero G, and Esposito F. Adaptation to oxidative stress, chemoresistance, and cell survival. Antioxid Redox Signal 11: 2701-2716, 2009.
198. Lau A, Villeneuve NF, Sun Z, Wong PK, and Zhang DD. Dual roles of Nrf2 in cancer. Pharmacol Res 58: 262-270, 2008.
199. Lau D and Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol Ther 111: 16-26, 2006. (Pubitemid 43765542)
200. Laurent G, Solari F, Mateescu B, Karaca M, Castel J, Bourachot B, Magnan C, Billaud M, and Mechta-Grigoriou F. Oxidative stress contributes to aging by enhancing pancreatic angiogenesis and insulin signaling. Cell Metab 7: 113-124, 2008. (Pubitemid 351181006)
201. Le S, Connors TJ, and Maroney AC. c-Jun N-terminal kinase specifically phosphorylates p66ShcA at serine 36 in response to ultraviolet irradiation. J Biol Chem 276: 48332-48336, 2001.
202. Lebedeva MA, Eaton JS, and Shadel GS. Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis. Biochim Biophys Acta 1787: 328-334, 2009.
203. Lee JW, Bae SH, Jeong JW, Kim SH, and Kim KW. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med 36: 1-12, 2004.
204. Lee OH, Jain AK, Papusha V, and Jaiswal AK. An autoregulatory loop between stress sensors INrf2 and Nrf2 controls their cellular abundance. J Biol Chem 282: 36412-36420, 2007.
205. Lee SJ, Seo KW, Yun MR, Bae SS, Lee WS, Hong KW, and Kim CD. 4-Hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROSmediated activation of the Akt/NF-kappaB signaling pathways. Free Radic Biol Med 45: 1487-1492, 2008.
206. Lee SR, Yang KS, Kwon J, Lee C, Jeong W, and Rhee SG. Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem 277: 20336-20342, 2002. (Pubitemid 34967328)
207. Lee WK and Thevenod F. A role for mitochondrial aquaporins in cellular life-and-death decisions? Am J Physiol Cell Physiol 291: C195-C202, 2006. (Pubitemid 44148141)
208. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, Crowe RA, Cascio WE, Bradham CA, Brenner DA, and Herman B. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1366: 177-196, 1998. (Pubitemid 28467031)
209. Lemasters JJ, Theruvath TP, Zhong Z, and Nieminen AL. Mitochondrial calcium and the permeability transition in cell death. Biochim Biophys Acta 1787: 1395-1401, 2009.
210. Lenaz G. The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life 52: 159-164, 2001. (Pubitemid 33731569)
211. Leonarduzzi G, Chiarpotto E, Biasi F, and Poli G. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol Nutr Food Res 49: 1044-1049, 2005. (Pubitemid 41735564)
212. Leto TL, Morand S, Hurt D, and Ueyama T. Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases. Antioxid Redox Signal 11: 2607-2619, 2009.
213. Levraut J, Iwase H, Shao ZH, Vanden Hoek TL, and Schumacker PT. Cell death during ischemia: relationship to mitochondrial depolarization and ROS generation. Am J Physiol Heart Circ Physiol 284: H549-H558, 2003. (Pubitemid 36142882)
214. Li C and Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 282: C227-C241, 2002. (Pubitemid 34663181)
215. Li M and Fukagawa NK. Age-related changes in redox signaling and VSMC function. Antioxid Redox Signal 12: 641-655, 2010.
216. Li N, Frigerio F, and Maechler P. The sensitivity of pancreatic beta-cells to mitochondrial injuries triggered by lipotoxicity and oxidative stress. Biochem Soc Trans 36: 930-934, 2008.
217. Liao D, Corle C, Seagroves TN, and Johnson RS. Hypoxiainducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Cancer Res 67: 563-572, 2007. (Pubitemid 46192193)
218. Limon-Pacheco J and Gonsebatt ME. The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress. Mutat Res 674: 137-147, 2009.
219. Lin MT and Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443: 787-795, 2006. (Pubitemid 44622683)
220. Liu Q, He X, Liu Y, Du B, Wang X, Zhang W, Jia P, Dong J, Ma J, Li S, and Zhang H. NADPH oxidase-mediated generation of reactive oxygen species: a new mechanism for Xray-induced HeLa cell death. Biochem Biophys Res Commun 377: 775-779, 2008.
221. Liu T, Laurell C, Selivanova G, Lundeberg J, Nilsson P, and Wiman KG. Hypoxia induces p53-dependent transactivation and Fas/CD95-dependent apoptosis. Cell Death Differ 14: 411-421, 2007.
222. Liu Z, Lu H, Shi H, Du Y, Yu J, Gu S, Chen X, Liu KJ, and Hu CA. PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells. Cancer Res 65: 1647-1654, 2005. (Pubitemid 40478588)
223. Lopez-Torres M, Perez-Campo R, Rojas C, Cadenas S, and Barja G. Maximum life span in vertebrates: relationship with liver antioxidant enzymes, glutathione system, ascorbate, urate, sensitivity to peroxidation, true malondialdehyde, in vivo H2O2, and basal and maximum aerobic capacity. Mech Ageing Dev 70: 177-199, 1993.
224. Lu Z, Xu X, Hu X, Fassett J, Zhu G, Tao Y, Li J, Huang Y, Zhang P, Zhao B, and Chen Y. PGC-1 alpha regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload. Antioxid Redox Signal 13: 1011-1022, 2010.
225. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, Trinchese F, Liu S, Gunn-Moore F, Lue LF, Walker DG, Kuppusamy P, Zewier ZL, Arancio O, Stern D, Yan SS, and Wu H. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304: 448-452, 2004. (Pubitemid 38495942)
226. Malhotra JD and Kaufman RJ. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a doubleedged sword? Antioxid Redox Signal 9: 2277-2293, 2007. (Pubitemid 350059010)
227. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, and Reddy PH. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15: 1437-1449, 2006.
228. Marengo B, De Ciucis C, Verzola D, Pistoia V, Raffaghello L, Patriarca S, Balbis E, Traverso N, Cottalasso D, Pronzato MA, Marinari UM, and Domenicotti C. Mechanisms of BSO (L-buthionine-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma. Free Radic Biol Med 44: 474-482, 2008.
229. Mari M, Colell A, Morales A, von Montfort C, Garcia-Ruiz C, and Fernandez-Checa JC. Redox control of liver function in health and disease. Antioxid Redox Signal 12: 1295-1331, 2010.
230. Marin-Hernandez A, Gallardo-Perez JC, Ralph SJ, Rodriguez-Enriquez S, and Moreno-Sanchez R. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem 9: 1084-1101, 2009.
231. Martin LJ, Pan Y, Price AC, Sterling W, Copeland NG, Jenkins NA, Price DL, and Lee MK. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci 26: 41-50, 2006. (Pubitemid 43089519)
232. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, and Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92: 1866-1874, 1993. (Pubitemid 23304554)
233. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, and Hwang PM. p53 regulates mitochondrial respiration. Science 312: 1650-1653, 2006. (Pubitemid 43902663)
234. Matsuoka T, Kajimoto Y, Watada H, Kaneto H, Kishimoto M, Umayahara Y, Fujitani Y, Kamada T, Kawamori R, and Yamasaki Y. Glycation-dependent, reactive oxygen speciesmediated suppression of the insulin gene promoter activity in HIT cells. J Clin Invest 99: 144-150, 1997. (Pubitemid 27058305)
235. Matsuura E, Kobayashi K, Tabuchi M, and Lopez LR. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog Lipid Res 45: 466-486, 2006. (Pubitemid 44331411)
236. Matsuzawa A, Nishitoh H, Tobiume K, Takeda K, and Ichijo H. Physiological roles of ASK1-mediated signal transduction in oxidative stress-and endoplasmic reticulum stress-induced apoptosis: advanced findings from ASK1 knockout mice. Antioxid Redox Signal 4: 415-425, 2002. (Pubitemid 34753381)
237. Maurer BJ, Metelitsa LS, Seeger RC, Cabot MC, and Reynolds CP. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines. J Natl Cancer Inst 91: 1138-1146, 1999. (Pubitemid 29330552)
238. Mauro MJ and Druker BJ. STI571: targeting BCR-ABL as therapy for CML. Oncologist 6: 233-238, 2001. (Pubitemid 32592214)
239. May JM and de Haen C. The insulin-like effect of hydrogen peroxide on pathways of lipid synthesis in rat adipocytes. J Biol Chem 254: 9017-9021, 1979. (Pubitemid 10239442)
240. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049-6055, 1969.
241. Micheau O and Lens S, Gaide O, Alevizopoulos K, Tschopp J. NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 21: 5299-5305, 2001. (Pubitemid 32702435)
242. Mieyal JJ, Gallogly MM, Qanungo S, Sabens EA, and Shelton MD. Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid Redox Signal 10: 1941-1988, 2008.
243. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP, Lanfrancone L, and Pelicci PG. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402: 309-313, 1999. (Pubitemid 129516269)
244. Miller RL, James-Kracke M, Sun GY, and Sun AY. Oxidative and inflammatory pathways in Parkinson's disease. Neurochem Res 34: 55-65, 2009.
245. Miller WH, Jr. Molecular targets of arsenic trioxide in malignant cells. Oncologist 7 Suppl 1: 14-19, 2002. (Pubitemid 34293056)
246. Miller WH, Jr., Schipper HM, Lee JS, Singer J, and Waxman S. Mechanisms of action of arsenic trioxide. Cancer Res 62: 3893-3903, 2002. (Pubitemid 34792653)
247. Misra MK, Sarwat M, Bhakuni P, Tuteja R, and Tuteja N. Oxidative stress and ischemic myocardial syndromes. Med Sci Monit 15: RA209-RA219, 2009.
248. Mitomo K, Nakayama K, Fujimoto K, Sun X, Seki S, and Yamamoto K. Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-kappa B in vitro. Gene 145: 197-203, 1994. (Pubitemid 24261434)
249. Morgan MJ, Kim YS, and Liu ZG. TNFalpha and reactive oxygen species in necrotic cell death. Cell Res 18: 343-349, 2008. (Pubitemid 351333898)
250. Morgan MJ and Liu ZG. Reactive oxygen species in TNFalpha-induced signaling and cell death. Mol Cells 30: 1-12, 2010.
251. Morgan WF, Day JP, Kaplan MI, McGhee EM, and Limoli CL. Genomic instability induced by ionizing radiation. Radiat Res 146: 247-258, 1996. (Pubitemid 26320088)
252. Mukherjee A and Martin SG. The thioredoxin system: a key target in tumour and endothelial cells. Br J Radiol 81 Spec No 1: S57-S68, 2008.
253. Murata H, Ihara Y, Nakamura H, Yodoi J, Sumikawa K, and Kondo T. Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J Biol Chem 278: 50226-50233, 2003. (Pubitemid 37548863)
254. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 417: 1-13, 2009.
255. Murry CE, Jennings RB, and Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986. (Pubitemid 17174962)
256. Nagel S, Talbot NP, Mecinovic J, Smith TG, Buchan AM, and Schofield CJ. Therapeutic manipulation of the HIF hydroxylases. Antioxid Redox Signal 12: 481-501, 2010.
257. Nakamura H, Nakamura K, and Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 15: 351-369, 1997. (Pubitemid 27169285)
258. Nakamura J, Kitajima Y, Kai K, Mitsuno M, Ide T, Hashiguchi K, Hiraki M, and Miyazaki K. Hypoxia-inducible factor-1alpha expression predicts the response to 5-fluorouracil-based adjuvant chemotherapy in advanced gastric cancer. Oncol Rep 22: 693-699, 2009.
259. Nakano H, Nakajima A, Sakon-Komazawa S, Piao JH, Xue X, and Okumura K. Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death Differ 13: 730-737, 2006.
260. Nakatani Y, Kaneto H, Kawamori D, Yoshiuchi K, Hatazaki M, Matsuoka TA, Ozawa K, Ogawa S, Hori M, Yamasaki Y, and Matsuhisa M. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J Biol Chem 280: 847-851, 2005. (Pubitemid 40165054)
261. Newsholme P, Haber EP, Hirabara SM, Rebelato EL, Procopio J, Morgan D, Oliveira-Emilio HC, Carpinelli AR, and Curi R. Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol 583: 9-24, 2007. (Pubitemid 47244241)
262. Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med 47: 469-484, 2009.
263. Nimnual AS, Taylor LJ, and Bar-Sagi D. Redox-dependent downregulation of Rho by Rac. Nat Cell Biol 5: 236-241, 2003. (Pubitemid 36322251)
264. Nishino T, Schopfer LM, and Massey V. The reactivity of chicken liver xanthine dehydrogenase with molecular oxygen. J Biol Chem 264: 2518-2527, 1989. (Pubitemid 19057739)
265. Niture SK, Jain AK, and Jaiswal AK. Antioxidant-induced modification of INrf2 cysteine 151 and PKC-delta-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance. J Cell Sci 122: 4452-4464, 2009.
266. Nogueira V, Park Y, Chen CC, Xu PZ, Chen ML, Tonic I, Unterman T, and Hay N. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14: 458-470, 2008.
267. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, and Smith MA. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60: 759-767, 2001. (Pubitemid 32678256)
268. Ohsumi Y. Molecular dissection of autophagy: two ubiquitin-like systems. Nat Rev Mol Cell Biol 2: 211-216, 2001. (Pubitemid 33675746)
269. Ohta T, Iijima K, Miyamoto M, Nakahara I, Tanaka H, Ohtsuji M, Suzuki T, Kobayashi A, Yokota J, Sakiyama T, Shibata T, Yamamoto M, and Hirohashi S. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res 68: 1303-1309, 2008. (Pubitemid 351346836)
270. Okamura S, Ng CC, Koyama K, Takei Y, Arakawa H, Monden M, and Nakamura Y. Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system. Oncol Res 11: 281-285, 1999.
271. Oltvai ZN and Barabasi AL. Systems biology. Life's complexity pyramid. Science 298: 763-764, 2002. (Pubitemid 35231516)
272. Orrenius S, Gogvadze V, and Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 47: 143-183, 2007.
273. Otani H. The role of nitric oxide in myocardial repair and remodeling. Antioxid Redox Signal 11: 1913-1928, 2009.
274. Ott M, Gogvadze V, Orrenius S, and Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis 12: 913-922, 2007. (Pubitemid 46653300)
275. Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, and Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci USA 99: 1259-1263, 2002. (Pubitemid 34136480)
276. Owusu-Ansah E and Banerjee U. Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation. Nature 461: 537-541, 2009.
277. Pacher P, Nivorozhkin A, and Szabo C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 58: 87-114, 2006.
278. Padmaja S and Huie RE. The reaction of nitric oxide with organic peroxyl radicals. Biochem Biophys Res Commun 195: 539-544, 1993. (Pubitemid 23280450)
279. Pani G, Giannoni E, Galeotti T, and Chiarugi P. Redoxbased escape mechanism from death: the cancer lesson. Antioxid Redox Signal 11: 2791-2806, 2009.
280. Paolini M, Perocco P, Canistro D, Valgimigli L, Pedulli GF, Iori R, Croce CD, Cantelli-Forti G, Legator MS, and Abdel-Rahman SZ. Induction of cytochrome P450, generation of oxidative stress and in vitro cell-transforming and DNAdamaging activities by glucoraphanin, the bioprecursor of the chemopreventive agent sulforaphane found in broccoli. Carcinogenesis 25: 61-67, 2004. (Pubitemid 38139226)
281. Papa S, Zazzeroni F, Bubici C, Jayawardena S, Alvarez K, Matsuda S, Nguyen DU, Pham CG, Nelsbach AH, Melis T, De Smaele E, Tang WJ, D'Adamio L, and Franzoso G. Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2. Nat Cell Biol 6: 146-153, 2004. (Pubitemid 38425714)
282. Parmar K, Mauch P, Vergilio JA, Sackstein R, and Down JD. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci USA 104: 5431-5436, 2007. (Pubitemid 47175697)
283. Patten DA, Germain M, Kelly MA, and Slack RS. Reactive oxygen species: stuck in the middle of neurodegeneration. J Alzheimers Dis 20 Suppl 2: S357-S367, 2010.
284. Pearce RK, Owen A, Daniel S, Jenner P, and Marsden CD. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J Neural Transm 104: 661-677, 1997. (Pubitemid 27474680)
285. Pendyala S, Usatyuk PV, Gorshkova IA, Garcia JG, and Natarajan V. Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins. Antioxid Redox Signal 11: 841-860, 2009.
286. Pennington JD, Wang TJ, Nguyen P, Sun L, Bisht K, Smart D, and Gius D. Redox-sensitive signaling factors as a novel molecular targets for cancer therapy. Drug Resist Updat 8: 322-330, 2005. (Pubitemid 41677715)
287. Peralta C, Bulbena O, Xaus C, Prats N, Cutrin JC, Poli G, Gelpi E, and Rosello-Catafau J. Ischemic preconditioning: a defense mechanism against the reactive oxygen species generated after hepatic ischemia reperfusion. Transplantation 73: 1203-1211, 2002. (Pubitemid 34454264)
288. Perl AK, Wilgenbus P, Dahl U, Semb H, and Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190-193, 1998. (Pubitemid 28162793)
289. Pesce V, Cormio A, Fracasso F, Vecchiet J, Felzani G, Lezza AM, Cantatore P, and Gadaleta MN. Age-related mitochondrial genotypic and phenotypic alterations in human skeletal muscle. Free Radic Biol Med 30: 1223-1233, 2001. (Pubitemid 32463933)
290. Peters EA, Hiltermann JT, and Stolk J. Effect of apocynin on ozone-induced airway hyperresponsiveness to methacholine in asthmatics. Free Radic Biol Med 31: 1442-1447, 2001. (Pubitemid 33145314)
291. Pettersson HM, Karlsson J, Pietras A, Ora I, and Pahlman S. Arsenic trioxide and neuroblastoma cytotoxicity. J Bioenerg Biomembr 39: 35-41, 2007. (Pubitemid 46877171)
292. Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K, Jayawardena S, De Smaele E, Cong R, Beaumont C, Torti FM, Torti SV, and Franzoso G. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 119: 529-542, 2004. (Pubitemid 39482352)
293. Piro M, Giubilato G, Pinnelli M, Giordano Sciacca P, and Biasucci LM. Endothelium and inflammation. Panminerva Med 47: 75-80, 2005. (Pubitemid 41634928)
294. Platanias LC. Biological responses to arsenic compounds. J Biol Chem 284: 18583-18587, 2009.
295. Poli G, Biasi F, and Leonarduzzi G. 4-Hydroxynonenalprotein adducts: a reliable biomarker of lipid oxidation in liver diseases. Mol Aspects Med 29: 67-71, 2008.
296. Poredos P. Endothelial dysfunction in the pathogenesis of atherosclerosis. Clin Appl Thromb Hemost 7: 276-280, 2001. (Pubitemid 32988889)
297. Porosnicu M, Nimmanapalli R, Nguyen D, Worthington E, Perkins C, and Bhalla KN. Co-treatment with As2O3 enhances selective cytotoxic effects of STI-571 against Brc-Abl-positive acute leukemia cells. Leukemia 15: 772-778, 2001. (Pubitemid 32496146)
298. Porte S, Valencia E, Yakovtseva EA, Borras E, Shafqat N, Debreczeny JE, and Pike AC, Oppermann U, Farres J, Fita I, Pares X. Three-dimensional structure and enzymatic function of proapoptotic human p53-inducible quinone oxidoreductase PIG3. J Biol Chem 284: 17194-17205, 2009.
299. Puigserver P, Rhee J, Lin J, Wu Z, Yoon JC, Zhang CY, Krauss S, Mootha VK, Lowell BB, and Spiegelman BM. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol Cell 8: 971-982, 2001. (Pubitemid 34031800)
300. Puigserver P and Spiegelman BM. Peroxisome proliferatoractivated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 24: 78-90, 2003. (Pubitemid 36223280)
301. Rabinovitch A. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 14: 129-151, 1998. (Pubitemid 28346261)
302. Radi R, Rubbo H, Bush K, and Freeman BA. Xanthine oxidase binding to glycosaminoglycans: kinetics and superoxide dismutase interactions of immobilized xanthine oxidase-heparin complexes. Arch Biochem Biophys 339: 125-135, 1997. (Pubitemid 27199762)
303. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, Werb Z, and Bissell MJ. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436: 123-127, 2005. (Pubitemid 40966197)
304. Rankin EB and Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 15: 678-685, 2008. (Pubitemid 351405072)
305. Ray R and Shah AM. NADPH oxidase and endothelial cell function. Clin Sci (Lond) 109: 217-226, 2005. (Pubitemid 41337126)
306. Reddy PH. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease. J Neurochem 96: 1-13, 2006.
307. Rehman F, Shanmugasundaram P, and Schrey MP. Fenretinide stimulates redox-sensitive ceramide production in breast cancer cells: potential role in drug-induced cytotoxicity. Br J Cancer 91: 1821-1828, 2004. (Pubitemid 39664971)
308. Rey FE, Cifuentes ME, Kiarash A, Quinn MT, and Pagano PJ. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2) and systolic blood pressure in mice. Circ Res 89: 408-414, 2001. (Pubitemid 34132656)
309. Reynaert NL, van der Vliet A, Guala AS, McGovern T, Hristova M, Pantano C, Heintz NH, Heim J, Ho YS, Matthews DE, Wouters EF, and Janssen-Heininger YM. Dynamic redox control of NF-kappaB through glutaredoxinregulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci USA 103: 13086-13091, 2006. (Pubitemid 44338920)
310. Richter C, Park JW, and Ames BN. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 85: 6465-6467, 1988.
311. Rojo AI, Innamorato NG, Martin-Moreno AM, De Ceballos ML, Yamamoto M, and Cuadrado A. Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease. Glia 58: 588-598, 2010.
312. Rollig C and Illmer T. The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: a systematic review. Cancer Treat Rev 35: 425-430, 2009.
313. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62, 1993. (Pubitemid 23087289)
314. Rotilio G, Aquilano K, and Ciriolo MR. Interplay of Cu, Zn superoxide dismutase and nitric oxide synthase in neurodegenerative processes. IUBMB Life 55: 629-634, 2003. (Pubitemid 38019842)
315. Sainani GS and Maru VG. Role of endothelial cell dysfunction in essential hypertension. J Assoc Physicians India 52: 966-969, 2004. (Pubitemid 41279959)
316. Salceda S and Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitinproteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272: 22642-22647, 1997. (Pubitemid 27386079)
317. Sanz A, Pamplona R, and Barja G. Is the mitochondrial free radical theory of aging intact? Antioxid Redox Signal 8: 582-599, 2006. (Pubitemid 43741327)
318. Sarkar FH and Li Y. Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metastasis Rev 21: 265-280, 2002. (Pubitemid 36071914)
319. Sastre J, Pallardo FV, Pla R, Pellin A, Juan G, O'Connor JE, Estrela JM, Miquel J, and Vina J. Aging of the liver: ageassociated mitochondrial damage in intact hepatocytes. Hepatology 24: 1199-1205, 1996. (Pubitemid 26365926)
320. Satoh K, Nigro P, and Berk BC. Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin A. Antioxid Redox Signal 12: 675-682, 2010.
321. Saugstad OD. Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury. Pediatrics 98: 103-107, 1996. (Pubitemid 26226981)
322. Savage DG and Antman KH. Imatinib mesylate-a new oral targeted therapy. N Engl J Med 346: 683-693, 2002. (Pubitemid 34815874)
323. Scherman D, Desnos C, Darchen F, Pollak P, Javoy-Agid F, and Agid Y. Striatal dopamine deficiency in Parkinson's disease: role of aging. Ann Neurol 26: 551-557, 1989. (Pubitemid 19247232)
324. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, and Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 26: 1749-1760, 2007. (Pubitemid 46624042)
325. Schmitz G and Grandl M. Role of redox regulation and lipid rafts in macrophages during Ox-LDL-mediated foam cell formation. Antioxid Redox Signal 9: 1499-1518, 2007. (Pubitemid 47255028)
326. Schroder K, Vecchione C, Jung O, Schreiber JG, Shiri-Sverdlov R, van Gorp PJ, Busse R, and Brandes RP. Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Westerntype diet. Free Radic Biol Med 41: 1353-1360, 2006. (Pubitemid 44479882)
327. Schulz JB and Beal MF. Mitochondrial dysfunction in movement disorders. Curr Opin Neurol 7: 333-339, 1994. (Pubitemid 24243738)
328. Selley ML, Bartlett MR, Czeti AL, and Ardlie NG. The role of (E)-4-hydroxy-2-nonenal in platelet activation by low density lipoprotein and iron. Atherosclerosis 140: 105-112, 1998. (Pubitemid 28378460)
329. Semenza GL. Perspectives on oxygen sensing. Cell 98: 281-284, 1999. (Pubitemid 29380563)
330. Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29: 625-634, 2010.
331. Semenza GL, Shimoda LA, and Prabhakar NR. Regulation of gene expression by HIF-1. Novartis Found Symp 272: 2-8; discussion 8-14, 33-36, 2006.
332. Sheehan D and Meade G. Chemical modulation of chemotherapy resistance in cultured oesophageal carcinoma cells. Biochem Soc Trans 28: 27-32, 2000. (Pubitemid 30103208)
333. Shelton MD, Distler AM, Kern TS, and Mieyal JJ. Glutaredoxin regulates autocrine and paracrine proinflammatory responses in retinal glial (muller) cells. J Biol Chem 284: 4760-4766, 2009.
334. Shelton MD, Kern TS, and Mieyal JJ. Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Muller cells: model of diabetic retinopathy. J Biol Chem 282: 12467-12474, 2007. (Pubitemid 47100623)
335. Shelton MD and Mieyal JJ. Regulation by reversible Sglutathionylation: molecular targets implicated in inflammatory diseases. Mol Cells 25: 332-346, 2008.
336. Shimabukuro M, Ohneda M, Lee Y, and Unger RH. Role of nitric oxide in obesity-induced beta cell disease. J Clin Invest 100: 290-295, 1997. (Pubitemid 27349075)
337. Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson CB, and Tsujimoto Y. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 6: 1221-1228, 2004. (Pubitemid 39625121)
338. Silva A, Yunes JA, Cardoso BA, Martins LR, Jotta PY, Abecasis M, Nowill AE, Leslie NR, Cardoso AA, and Barata JT. PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability. J Clin Invest 118: 3762-3774, 2008.
339. Silvestri L, Caputo V, Bellacchio E, Atorino L, Dallapiccola B, Valente EM, and Casari G. Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet 14: 3477-3492, 2005. (Pubitemid 41672130)
340. Singh R, Kanwar SS, Sood PK, and Nehru B. Beneficial effects of folic acid on enhancement of memory and antioxidant status in aged rat brain. Cell Mol Neurobiol 31: 83-91, 2011.
341. Snow BJ, Rolfe FL, Lockhart MM, Frampton CM, O'Sullivan JD, Fung V, Smith RA, Murphy MP, and Taylor KM. A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a diseasemodifying therapy in Parkinson's disease. Mov Disord 25: 1670-1674, 2010.
342. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J, Scheinberg DA, Pandolfi PP, and Warrell RP, Jr. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 339: 1341-1348, 1998. (Pubitemid 28509343)
343. Sourris KC and Forbes JM. Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy-are these receptors valid therapeutic targets. Curr Drug Targets 10: 42-50, 2009.
344. Spitz DR, Azzam EI, Li JJ, and Gius D. Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology. Cancer Metastasis Rev 23: 311-322, 2004. (Pubitemid 38881814)
345. Srivastava SK, Ramana KV, and Bhatnagar A. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev 26: 380-392, 2005. (Pubitemid 40691299)
346. St-Pierre J, Buckingham JA, Roebuck SJ, and Brand MD. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem 277: 44784-44790, 2002. (Pubitemid 36159072)
347. Steegmann JL, Moreno G, Alaez C, Osorio S, Granda A, de la Camara R, Arranz E, Reino FG, Salvanes FR, Fernandez-Ranada JM, and Munoz C. Chronic myeloid leukemia patients resistant to or intolerant of interferon alpha and subsequently treated with imatinib show reduced immunoglobulin levels and hypogammaglobulinemia. Haematologica 88: 762-768, 2003. (Pubitemid 36890110)
348. Stewart D, Killeen E, Naquin R, Alam S, and Alam J. Degradation of transcription factor Nrf2 via the ubiquitinproteasome pathway and stabilization by cadmium. J Biol Chem 278: 2396-2402, 2003. (Pubitemid 36801313)
349. Stuehr DJ, Fasehun OA, Kwon NS, Gross SS, Gonzalez JA, Levi R, and Nathan CF. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 5: 98-103, 1991. (Pubitemid 21892842)
350. Sumi D, Shinkai Y, and Kumagai Y. Signal transduction pathways and transcription factors triggered by arsenic trioxide in leukemia cells. Toxicol Appl Pharmacol 244: 385-392, 2010.
351. Suzuki S, Tanaka T, Poyurovsky MV, Nagano H, Mayama T, Ohkubo S, Lokshin M, Hosokawa H, Nakayama T, Suzuki Y, Sugano S, Sato E, Nagao T, Yokote K, Tatsuno I, and Prives C. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci USA 107: 7461-7466, 2010.
352. Suzuki Y, Ono Y, and Hirabayashi Y. Rapid and specific reactive oxygen species generation via NADPH oxidase activation during Fas-mediated apoptosis. FEBS Lett 425: 209-212, 1998. (Pubitemid 28178891)
353. Svineng G, Ravuri C, Rikardsen O, Huseby NE, and Winberg JO. The role of reactive oxygen species in integrin and matrix metalloproteinase expression and function. Connect Tissue Res 49: 197-202, 2008.
354. Szeto HH. Cell-permeable, mitochondrial-targeted, peptide antioxidants. AAPS J 8: E277-E283, 2006.
355. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT, and Donahoe PK. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci USA 103: 11154-11159, 2006. (Pubitemid 44156488)
356. Taha MO, Simoes MJ, Noguerol EC, Mendonca FP, Pascoalick HM, Alves RA, Vivian ME, Morales FP, Campos AC, Magalhaes KG, Venerando PS, Tersariol IL, Monteiro HP, Oliveira-Junior IS, Jurkiewicz A, and Caricati-Neto A. Effects of allopurinol on ischemia and reperfusion in rabbit livers. Transplant Proc 41: 820-823, 2009.
357. Tamatani M, Che YH, Matsuzaki H, Ogawa S, Okado H, Miyake S, Mizuno T, and Tohyama M. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J Biol Chem 274: 8531-8538, 1999. (Pubitemid 29164643)
358. Tan S, Gelman S, Wheat JK, and Parks DA. Circulating xanthine oxidase in human ischemia reperfusion. South Med J 88: 479-482, 1995.
359. Tan S, Yokoyama Y, Dickens E, Cash TG, Freeman BA, and Parks DA. Xanthine oxidase activity in the circulation of rats following hemorrhagic shock. Free Radic Biol Med 15: 407-414, 1993. (Pubitemid 23283557)
360. Taniyama Y and Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42: 1075-1081, 2003. (Pubitemid 37549058)
361. Thannickal VJ and Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005-L1028, 2000. (Pubitemid 32009487)
362. Thornborrow EC, Patel S, Mastropietro AE, Schwartzfarb EM, and Manfredi JJ. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes. Oncogene 21: 990-999, 2002. (Pubitemid 34174511)
363. Tibbles LA and Woodgett JR. The stress-activated protein kinase pathways. Cell Mol Life Sci 55: 1230-1254, 1999. (Pubitemid 29410745)
364. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T, and Ichijo H. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2: 222-228, 2001. (Pubitemid 32273301)
365. Toledano MB and Leonard WJ. Modulation of transcription factor NF-kappa B binding activity by oxidationreduction in vitro. Proc Natl Acad Sci USA 88: 4328-4332, 1991. (Pubitemid 21914533)
366. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, and Davis RJ. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288: 870-874, 2000. (Pubitemid 30257738)
367. Townsend DM, Tew KD, and Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother 57: 145-155, 2003. (Pubitemid 36740460)
368. Tsukagoshi H, Busch W, and Benfey PN. Transcriptional regulation of ROS controls transition from proliferation to differentiation in the root. Cell 143: 606-616, 2010.
369. Tu BP and Weissman JS. The FAD-and O(2)-dependent reaction cycle of Ero1-mediated oxidative protein folding in the endoplasmic reticulum. Mol Cell 10: 983-994, 2002. (Pubitemid 35453820)
370. Tu BP and Weissman JS. Oxidative protein folding in eukaryotes: mechanisms and consequences. J Cell Biol 164: 341-346, 2004. (Pubitemid 38174761)
371. Tuominen EK, Wallace CJ, and Kinnunen PK. Phospholipid-cytochrome c interaction: evidence for the extended lipid anchorage. J Biol Chem 277: 8822-8826, 2002. (Pubitemid 34952948)
372. Turrens JF, Alexandre A, and Lehninger AL. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys 237: 408-414, 1985. (Pubitemid 15144894)
373. Ulukaya E and Wood EJ. Fenretinide and its relation to cancer. Cancer Treat Rev 25: 229-235, 1999. (Pubitemid 29417680)
374. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fujimoto M, Quinn MT, Pagano PJ, Johnson C, and Alexander RW. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factorinduced signaling and angiogenesis. Circ Res 91: 1160-1167, 2002. (Pubitemid 36076365)
375. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, and Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271: 23317-23321, 1996. (Pubitemid 26314775)
376. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, and Wood NW. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304: 1158-1160, 2004. (Pubitemid 38661852)
377. Valko M, Morris H, and Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem 12: 1161-1208, 2005. (Pubitemid 40655271)
378. Van den Worm E, Beukelman CJ, Van den Berg AJ, Kroes BH, Labadie RP, and Van Dijk H. Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils. Eur J Pharmacol 433: 225-230, 2001. (Pubitemid 34045183)
379. Van Houten B, Woshner V, and Santos JH. Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair (Amst) 5: 145-152, 2006. (Pubitemid 43069515)
380. Van Remmen H, Ikeno Y, Hamilton M, Pahlavani M, Wolf N, Thorpe SR, Alderson NL, Baynes JW, Epstein CJ, Huang TT, Nelson J, Strong R, and Richardson A. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics 16: 29-37, 2003. (Pubitemid 38420018)
381. van Roy F and Berx G. The cell-cell adhesion molecule Ecadherin. Cell Mol Life Sci 65: 3756-3788, 2008.
382. Ventura JJ, Cogswell P, Flavell RA, Baldwin AS, Jr., and Davis RJ. JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. Genes Dev 18: 2905-2915, 2004. (Pubitemid 39602309)
383. Venugopal R and Jaiswal AK. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc Natl Acad Sci USA 93: 14960-14965, 1996. (Pubitemid 26419078)
384. Veronesi U, De Palo G, Marubini E, Costa A, Formelli F, Mariani L, Decensi A, Camerini T, Del Turco MR, Di Mauro MG, Muraca MG, Del Vecchio M, Pinto C, D'Aiuto G, Boni C, Campa T, Magni A, Miceli R, Perloff M, Malone WF, and Sporn MB. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J Natl Cancer Inst 91: 1847-1856, 1999.
385. Verschoor ML, Wilson LA, and Singh G. Mechanisms associated with mitochondrial-generated reactive oxygen species in cancer. Can J Physiol Pharmacol 88: 204-219, 2010.
386. Victor VM, Apostolova N, Herance R, Hernandez-Mijares A, and Rocha M. Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy. Curr Med Chem 16: 4654-4667, 2009.
387. Victor VM, Rocha M, Sola E, Banuls C, Garcia-Malpartida K, and Hernandez-Mijares A. Oxidative stress, endothelial dysfunction and atherosclerosis. Curr Pharm Des 15: 2988-3002, 2009.
388. Vincent AM, Perrone L, Sullivan KA, Backus C, Sastry AM, Lastoskie C, and Feldman EL. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 148: 548-558, 2007. (Pubitemid 46143159)
389. Violi F, Basili S, Nigro C, and Pignatelli P. Role of NADPH oxidase in atherosclerosis. Future Cardiol 5: 83-92, 2009.
390. Wang G, Li W, Cui J, Gao S, Yao C, Jiang Z, Song Y, Yuan CJ, Yang Y, Liu Z, and Cai L. An efficient therapeutic approach to patients with acute promyelocytic leukemia using a combination of arsenic trioxide with low-dose alltrans retinoic acid. Hematol Oncol 22: 63-71, 2004. (Pubitemid 39410010)
391. Wang J, Li L, Cang H, Shi G, and Yi J. NADPH oxidasederived reactive oxygen species are responsible for the high susceptibility to arsenic cytotoxicity in acute promyelocytic leukemia cells. Leuk Res 32: 429-436, 2008. (Pubitemid 351295909)
392. Wang K, Fang H, Xiao D, Zhu X, He M, Pan X, Shi J, Zhang H, Jia X, Du Y, and Zhang J. Converting redox signaling to apoptotic activities by stress-responsive regulators HSF1 and NRF2 in fenretinide treated cancer cells. PLoS One 4: e7538, 2009.
393. Wang L, Azad N, Kongkaneramit L, Chen F, Lu Y, Jiang BH, and Rojanasakul Y. The Fas death signaling pathway connecting reactive oxygen species generation and FLICE inhibitory protein down-regulation. J Immunol 180: 3072-3080, 2008.
394. Watson JD and Crick FH. Genetical implications of the structure of deoxyribonucleic acid. Nature 171: 964-967, 1953.
395. Waxman K. Shock: ischemia, reperfusion, and inflammation. New Horiz 4: 153-160, 1996. (Pubitemid 26171424)
396. Weissig V and Torchilin VP. Mitochondriotropic cationic vesicles: a strategy towards mitochondrial gene therapy. Curr Pharm Biotechnol 1: 325-346, 2000.
397. Weissig V and Torchilin VP. Towards mitochondrial gene therapy: DQAsomes as a strategy. J Drug Target 9: 1-13, 2001. (Pubitemid 32496446)
398. Wells DM, Wilson MH, and Bennett MJ. Feeling UPBEAT about growth: linking ROS gradients and cell proliferation. Dev Cell 19: 644-646, 2010.
399. West JD and Marnett LJ. Endogenous reactive intermediates as modulators of cell signaling and cell death. Chem Res Toxicol 19: 173-194, 2006.
400. Westermarck J and Kahari VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792, 1999. (Pubitemid 29220691)
401. Whitworth AJ, Theodore DA, Greene JC, Benes H, Wes PD, and Pallanck LJ. Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease. Proc Natl Acad Sci USA 102: 8024-8029, 2005. (Pubitemid 40781056)
402. Wild AC, Moinova HR, and Mulcahy RT. Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J Biol Chem 274: 33627-33636, 1999. (Pubitemid 129511675)
403. Winterbourn CC, Parsons-Mair HN, Gebicki S, Gebicki JM, and Davies MJ. Requirements for superoxide-dependent tyrosine hydroperoxide formation in peptides. Biochem J 381: 241-248, 2004. (Pubitemid 38932230)
404. Wood ZA, Schroder E, Robin Harris J, and Poole LB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28: 32-40, 2003. (Pubitemid 36051004)
405. Wu WS, Wu JR, and Hu CT. Signal cross talks for sustained MAPK activation and cell migration: the potential role of reactive oxygen species. Cancer Metastasis Rev 27: 303-314, 2008.
406. Xiao L, Wang K, Teng Y, and Zhang J. Component plane presentation integrated self-organizing map for microarray data analysis. FEBS Lett 538: 117-124, 2003. (Pubitemid 36287436)
407. Ximenes VF, Kanegae MP, Rissato SR, and Galhiane MS. The oxidation of apocynin catalyzed by myeloperoxidase: proposal for NADPH oxidase inhibition. Arch Biochem Biophys 457: 134-141, 2007. (Pubitemid 46048700)
408. Yakes FM and Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 94: 514-519, 1997. (Pubitemid 27053665)
409. Yamada Y and Harashima H. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. Adv Drug Deliv Rev 60: 1439-1462, 2008.
410. Yamagishi S. Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications. Ther Apher Dial 13: 534-539, 2009.
411. Yamamoto E, Tamamaki N, Nakamura T, Kataoka K, Tokutomi Y, Dong YF, Fukuda M, Matsuba S, Ogawa H, and Kim-Mitsuyama S. Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation. Stroke 39: 3049-3056, 2008.
412. Yan SD and Stern DM. Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD). Int J Exp Pathol 86: 161-171, 2005. (Pubitemid 40813912)
413. Yeung BH, Wong KY, Lin MC, Wong CK, Mashima T, Tsuruo T, and Wong AS. Chemosensitisation by manganese superoxide dismutase inhibition is caspase-9 dependent and involves extracellular signal-regulated kinase 1/2. Br J Cancer 99: 283-293, 2008.
414. Yoon KA, Nakamura Y, and Arakawa H. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J Hum Genet 49: 134-140, 2004. (Pubitemid 38506727)
415. Yoshida H, Kitamura K, Tanaka K, Omura S, Miyazaki T, Hachiya T, Ohno R, and Naoe T. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. Cancer Res 56: 2945-2948, 1996. (Pubitemid 26199737)
416. Yoshiuchi K, Kaneto H,Matsuoka TA, Kohno K, Iwawaki T, Nakatani Y, Yamasaki Y, Hori M, and Matsuhisa M. Direct monitoring of in vivo ER stress during the development of insulin resistance with ER stress-activated indicator transgenic mice. Biochem Biophys Res Commun 366: 545-550, 2008. (Pubitemid 50010537)
417. Zangar RC, Davydov DR, and Verma S. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol Appl Pharmacol 199: 316-331, 2004. (Pubitemid 39208731)
418. Zhang DD and Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 23: 8137-8151, 2003. (Pubitemid 37377505)
419. Zhang J, Lu A, Li L, Yue J, and Lu Y. p16 Modulates VEGF expression via its interaction with HIF-1alpha in breast cancer cells. Cancer Invest 28: 588-597, 2010.
420. Zhang L, Yu L, and Yu CA. Generation of superoxide anion by succinate-cytochrome c reductase from bovine heart mitochondria. J Biol Chem 273: 33972-33976, 1998. (Pubitemid 29008862)
421. Zhang M, Brewer AC, Schroder K, Santos CX, Grieve DJ, Wang M, Anilkumar N, Yu B, Dong X, Walker SJ, Brandes RP, and Shah AM. NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci USA 107: 18121-18126, 2010.
422. Zhang Q, Wang SY, Nottke AC, Rocheleau JV, Piston DW, and Goodman RH. Redox sensor CtBP mediates hypoxiainduced tumor cell migration. Proc Natl Acad Sci USA 103: 9029-9033, 2006. (Pubitemid 43902527)
423. Zhao K, Zhao GM, Wu D, Soong Y, Birk AV, Schiller PW, and Szeto HH. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem 279: 34682-34690, 2004. (Pubitemid 39318098)
424. Zhao Y, Chaiswing L, Velez JM, Batinic-Haberle I, Colburn NH, Oberley TD, and St. Clair DK. p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res 65: 3745-3750, 2005. (Pubitemid 40616352)
425. Zheng PZ, Wang KK, Zhang QY, Huang QH, Du YZ, Zhang QH, Xiao DK, Shen SH, Imbeaud S, Eveno E, Zhao CJ, Chen YL, Fan HY, Waxman S, Auffray C, Jin G, Chen SJ, Chen Z, and Zhang J. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc Natl Acad Sci USA 102: 7653-7658, 2005. (Pubitemid 40741026)
426. Zhou GB, Zhang J, Wang ZY, Chen SJ, and Chen Z. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy. Philos Trans R Soc Lond B Biol Sci 362: 959-971, 2007. (Pubitemid 47056795)
427. Zimmerman MC, Oberley LW, and Flanagan SW. Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels. J Neurochem 102: 609-618, 2007. (Pubitemid 47057273)